Roesser J R, Liittschwager K, Leff S E
Department of Pharmacology, Stanford University, California 94305.
J Biol Chem. 1993 Apr 15;268(11):8366-75.
Transcripts of the rat calcitonin/calcitonin gene-related peptide (CGRP) gene are alternatively spliced in a tissue-specific manner resulting in the production of calcitonin mRNA and peptide in thyroid C cells and CGRP mRNA and peptide in neurons. Transfection studies using calcitonin and chimaeric human beta-globin/calcitonin exon minigene constructs showed that the splice acceptor and exon specific to calcitonin mRNA are spliced much less efficiently in CGRP-producing cells (F9 teratocarcinomas) than in cells that preferentially make calcitonin (HeLa cells). In vitro splicing of chimaeric human beta-globin/calcitonin transcripts in HeLa nuclear extracts were inhibited by the addition of nuclear extract from CGRP-favoring cells or tissues such as rat brain. This inhibition was specific as splicing of human beta-globin first intron transcripts was not affected by comparable amounts of rat brain extract. Fractionation of rat brain nuclear extracts allowed the partial purification of two brain-specific polypeptides of apparent molecular mass of 43 and 41 kDa which preferentially bind RNA containing the calcitonin-specific splice acceptor. Since these polypeptides cofractionate with the calcitonin mRNA-specific splicing inhibition activity, we suggest that they may mediate the inhibition of splicing observed in vitro and underlie, in part, the inefficient calcitonin mRNA production observed in CGRP-favoring cells in vivo.
大鼠降钙素/降钙素基因相关肽(CGRP)基因的转录本以组织特异性方式进行可变剪接,导致在甲状腺C细胞中产生降钙素mRNA和肽,在神经元中产生CGRP mRNA和肽。使用降钙素和嵌合人β-珠蛋白/降钙素外显子小基因构建体的转染研究表明,降钙素mRNA特异的剪接受体和外显子在产生CGRP的细胞(F9畸胎瘤)中的剪接效率远低于优先产生降钙素的细胞(HeLa细胞)。在HeLa细胞核提取物中,嵌合人β-珠蛋白/降钙素转录本的体外剪接受到来自CGRP偏好细胞或组织(如大鼠脑)的核提取物的抑制。这种抑制是特异性的,因为人β-珠蛋白第一个内含子转录本的剪接不受相当量大鼠脑提取物的影响。对大鼠脑细胞核提取物进行分级分离,可部分纯化出两种表观分子量分别为43 kDa和41 kDa的脑特异性多肽,它们优先结合含有降钙素特异性剪接受体的RNA。由于这些多肽与降钙素mRNA特异性剪接抑制活性共分级分离,我们认为它们可能介导了体外观察到的剪接抑制,并在一定程度上是体内CGRP偏好细胞中降钙素mRNA产生效率低下的基础。